Related Experiment Videos
Expression of Bcl-2 protects against photoreceptor degeneration in retinal degeneration slow (rds) mice
1Department of Pharmacology, University of Texas Health Science Center, San Antonio, Texas 78284, USA. nir@uthscsa.edu
Abstract:
The retinal degeneration slow or rds gene encodes rds/peripherin, an integral membrane glycoprotein in the outer segments of rod and cone photoreceptors. Mice homozygous for a null mutation in rds fail to develop outer segments and undergo subsequent degeneration of photoreceptors by the apoptotic pathway. Mutations in the human RDS gene are responsible for several forms of inherited blindness including autosomal-dominant retinitis pigmentosa and macular degeneration. Here, we examined the effects of ectopic Bcl-2 expression in transgenic photoreceptors on the rate of retinal degeneration in rds mutant mice. We observed an approximately twofold preservation of photoreceptors compared with nontransgenic rds mutant mice at 3 months. Immunoblot analysis showed similar levels of Bcl-2 in 2-, 3-, and 4-week-old transgenic mice. Expression of Bcl-2 in the rds mouse did not lead to outer segment formation and did not induce cell death. These results suggest that Bcl-2 expression may be an effective therapeutic strategy in humans with mutations in RDS or other genes that affect the integrity of photoreceptor outer segments.
Insights
Introducing Bcl-2 to retinal degeneration slow (RDS) mutant mice preserved photoreceptors, suggesting a potential therapeutic strategy for inherited blindness caused by RDS gene mutations.
Area of Science:
- Ophthalmology
- Genetics
- Cell Biology
Background:
- The retinal degeneration slow (RDS) gene encodes rds/peripherin, crucial for photoreceptor outer segment integrity.
- Mutations in the human RDS gene cause inherited blindness, including retinitis pigmentosa and macular degeneration.
- RDS-deficient mice exhibit photoreceptor degeneration via apoptosis due to failed outer segment development.
Purpose of the Study:
- To investigate the therapeutic potential of ectopic Bcl-2 expression in preserving photoreceptors in RDS-mutant mice.
- To determine if Bcl-2 influences outer segment formation or induces cell death in the absence of functional RDS.
Main Methods:
- Generated transgenic RDS-mutant mice with ectopic Bcl-2 expression in photoreceptors.
- Assessed photoreceptor survival rates at 3 months compared to non-transgenic controls.
- Utilized immunoblot analysis to confirm Bcl-2 levels in transgenic mice.
Main Results:
- Photoreceptor preservation was approximately twofold higher in Bcl-2-expressing RDS-mutant mice at 3 months.
- Bcl-2 expression did not restore outer segment formation in RDS-mutant photoreceptors.
- Ectopic Bcl-2 did not induce photoreceptor cell death in the absence of RDS.
Conclusions:
- Ectopic Bcl-2 expression significantly preserves photoreceptors in RDS-mutant mice, independent of outer segment formation.
- Bcl-2 may represent a viable therapeutic approach for inherited retinal diseases linked to photoreceptor outer segment integrity defects.
- This study highlights Bcl-2's anti-apoptotic role in mitigating photoreceptor loss in genetic blindness models.